Phase 1 Bariatric Surgery Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS)

Weight LossAlcohol Use DisorderBariatric Surgery Patients

Yale University10 enrolled1 locationNCT07223983

Recruiting

Phase 1

Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients

ObesitySmoking CessationBariatric Surgery Patients

Yale University20 enrolled1 locationNCT07224087

Recruiting

Phase 1

Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents

ObesityBariatric SurgeryAdolescent Obesity+3 more

University of Colorado, Denver40 enrolled1 locationNCT06575738